No connection

Search Results

NOTV vs TNON

NOTV
Inotiv, Inc.
BEARISH
Price
$0.24
Market Cap
$8.4M
Sector
Healthcare
AI Confidence
95%
TNON
Tenon Medical, Inc.
BEARISH
Price
$0.80
Market Cap
$9.0M
Sector
Healthcare
AI Confidence
90%

Valuation

P/E Ratio
NOTV
--
TNON
--
Forward P/E
NOTV
-4.9
TNON
-1.28
P/B Ratio
NOTV
0.08
TNON
4.41
P/S Ratio
NOTV
0.02
TNON
2.29
EV/EBITDA
NOTV
26.68
TNON
-0.72

Profitability

Gross Margin
NOTV
23.49%
TNON
59.79%
Operating Margin
NOTV
-13.36%
TNON
-193.52%
Profit Margin
NOTV
-13.5%
TNON
0.0%
ROE
NOTV
-49.76%
TNON
-228.06%
ROA
NOTV
-3.14%
TNON
-72.88%

Growth

Revenue Growth
NOTV
0.8%
TNON
92.3%
Earnings Growth
NOTV
--
TNON
--

Financial Health

Debt/Equity
NOTV
4.37
TNON
0.03
Current Ratio
NOTV
0.3
TNON
2.11
Quick Ratio
NOTV
0.17
TNON
1.7

Dividends

Dividend Yield
NOTV
--
TNON
--
Payout Ratio
NOTV
0.0%
TNON
0.0%

AI Verdict

NOTV BEARISH

NOTV exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9, indicating severe fundamental weakness. The company is facing a liquidity crisis with a Current Ratio of 0.30 and a Quick Ratio of 0.17, suggesting it cannot meet its short-term obligations. High leverage (Debt/Equity of 4.37) combined with stagnant revenue growth (0.80%) and consistent earnings misses creates a high risk of insolvency. The catastrophic 5-year price decline of 98.8% and bearish insider activity further confirm a negative outlook.

Strengths
Positive Gross Margin (23.49%)
Extremely low Price-to-Sales ratio (0.02)
Extremely low Price-to-Book ratio (0.08)
Risks
Severe liquidity risk (Current Ratio 0.30)
Excessive leverage (Debt/Equity 4.37)
Consistent failure to meet earnings estimates (0/4 beats)
TNON BEARISH

TNON exhibits critical financial fragility with a Piotroski F-Score of 1/9, signaling severe weakness in profitability and operational efficiency. While the company shows impressive top-line momentum with 92.3% YoY revenue growth and maintains a low debt profile, these are overshadowed by a catastrophic -193.52% operating margin and a -228.06% ROE. The long-term price performance is devastating, with a near 100% loss over 5 years, suggesting a failed historical value proposition. Despite optimistic analyst price targets, the deterministic health metrics indicate a high risk of continued equity erosion.

Strengths
Strong YoY revenue growth of 92.30%
High gross margin of 59.79% indicating product value
Very low leverage with a Debt/Equity ratio of 0.03
Risks
Critical financial health as evidenced by Piotroski F-Score of 1/9
Severe operational losses with an operating margin of -193.52%
Extreme equity erosion indicated by ROE of -228.06%

Compare Another Pair

NOTV vs TNON: Head-to-Head Comparison

This page compares Inotiv, Inc. (NOTV) and Tenon Medical, Inc. (TNON) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile